Published in Eur J Surg Oncol on September 01, 2002
Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol (2009) 1.23
Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87
Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ (2006) 0.84
False-negative sentinel node biopsy. Ann Surg Oncol (2009) 0.83
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma (EJSO 2002; 28: 673--678). Eur J Surg Oncol (2003) 0.75
Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients. Ann Surg Oncol (2016) 0.75
Features of sentinel lymph nodes for melanoma may lead to re-diagnosis of the cutaneous primary: an unusual case and review of literature. Virchows Arch (2004) 0.75
Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol (2007) 3.53
Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther (2010) 3.42
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med (2001) 2.18
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
High prevalence of pseudotumors in patients with a Birmingham Hip Resurfacing prosthesis: a prospective cohort study of one hundred and twenty-nine patients. J Bone Joint Surg Am (2013) 1.87
Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer. Hum Genet (1990) 1.84
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol (1995) 1.60
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration. Cancer (1987) 1.50
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Sentinel node detection in patients with breast cancer: low-energy all-purpose collimator or medium-energy collimator? Clin Nucl Med (2004) 1.47
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant (1990) 1.43
Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med (2004) 1.43
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
[AL-amyloidosis and its treatment by eliminating the precursor protein]. Ned Tijdschr Geneeskd (2007) 1.39
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis. Amyloid (2001) 1.38
The current status of S-100B as a biomarker in melanoma. Eur J Surg Oncol (2012) 1.34
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med (1995) 1.30
Genetic predisposition to testicular germ-cell tumours. Lancet Oncol (2004) 1.28
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.23
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Malignant parotid tumors: clinical use of MR imaging and histologic correlation. Radiology (1992) 1.21
Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood (1995) 1.19
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg (1995) 1.17
Familial testicular cancer in a single-centre population. Eur J Cancer (1999) 1.17
Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin. J Clin Oncol (1989) 1.16
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma. J Cancer Res Clin Oncol (1989) 1.16
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
External and internal hemipelvectomy for sarcomas of the pelvic girdle: consequences of limb-salvage treatment. Eur J Surg Oncol (1997) 1.15
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav (2001) 1.13
[Efficient and improved diagnosis of osteoporosis by simultaneous bone density measurement and spinal morphometry]. Ned Tijdschr Geneeskd (2008) 1.12
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer (2005) 1.12
Effect of manual percussion on tracheobronchial clearance in patients with chronic airflow obstruction and excessive tracheobronchial secretion. Thorax (1986) 1.11
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med (1996) 1.11
A standrard method for DNCB sensitization testing in patients with neoplasms. Cancer (1974) 1.11
Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest (1989) 1.10
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls. Eur J Nucl Med Mol Imaging (2008) 1.08
Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines. Ann N Y Acad Sci (1975) 1.08
The significance of the doctor-patient relationship in coping with cancer. Soc Sci Med (1984) 1.05
Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg (1997) 1.05
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J Clin Endocrinol Metab (1996) 1.04
Soft tissue sarcoma--compliance with guidelines. Cancer (2001) 1.04
Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med (1989) 1.04
Asymptomatic pseudotumours after metal-on-metal hip resurfacing show little change within one year. Bone Joint J (2013) 1.03
The effect of chemotherapy on the growing skeleton. Cancer Treat Rev (2000) 1.03
Quality of life in bone tumor patients comparing limb salvage and amputation of the lower extremity. J Surg Oncol (1992) 1.02
Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis. Eur J Nucl Med (1990) 1.01
Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol (2008) 1.01
Osteosarcoma of the pelvis--oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol (2000) 1.01
Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol (2009) 1.01
Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest (1989) 1.01
Effect of positive expiratory pressure breathing in patients with cystic fibrosis. Thorax (1991) 1.01
Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Endoscopy (2008) 1.00
Outcome of surgical treatment for carotid body paraganglioma. Br J Surg (2001) 1.00
Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann Intern Med (1992) 1.00